In line with the preferential dephosphorylation of CD28 by PD-1 in the aforementioned cell free assay (14), Kamphorst et al. demonstrated that the blockade of CD80/CD86 attenuated the therapeutic effects of anti-PD-L1 Ab against CT26 colon tumor cells (52). This evidence concerns the gene CD80 and colonic neoplasm.